ArticleFrontiers in cellular and infection microbiology2026
The diagnostic role of albumin-based ratio markers for periprosthetic joint infection.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Periprosthetic joint infection (PJI) is a serious complication following total joint arthroplasty. Timely and accurate diagnosis is crucial for the management of PJI. Numerous biomarkers are currently available for the diagnosis of PJI; however, a single indicator often fails to meet clinical requirements. In recent years, combinations of multiple biomarkers have demonstrated diagnostic potential in other infectious diseases. Nevertheless, the application of inflammatory marker combinations based on albumin (ALB) ratios in PJI diagnosis remains underexplored. Therefore, this study aims to investigate the diagnostic efficacy of novel biomarkers based on albumin ratios for PJI. Methods: A retrospective analysis was conducted on 257 patients with periprosthetic joint infection (PJI) and 137 with aseptic loosening (AL) who underwent revision arthroplasty at our institution between January 2019 and December 2024. We compared serum levels of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), albumin (ALB), the CRP/ALB ratio (CAR), the ESR/ALB ratio (EAR), and the composite index CAR + EAR (CEAR) between the two groups. Diagnostic performance was assessed using receiver operating characteristic (ROC) curves and the corresponding area under the ROC curve (AUC). Results: Patients with PJI exhibited significantly higher circulating levels of CRP, ESR, CAR, EAR and CEAR, whereas serum albumin was markedly lower than in the AL cohort. Subgroup analyses revealed no significant differences in the levels of these inflammatory biomarkers among the subgroups (P > 0.05). Based on ROC curve analysis, the novel inflammatory biomarker panels (CAR, EAR, CEAR) demonstrated high diagnostic accuracy: CAR yielded an AUC of 0.929 (95% CI: 0.905-0.953), EAR 0.890 (95% CI: 0.860-0.921), and CEAR 0.917 (95% CI: 0.890-0.943). Conclusion: Ratio-based markers based on ALB show promise as valuable new adjunctive diagnostic markers for PJI. The diagnostic efficacy of CEAR was comparable to that of CAR (AUC: 0.917 vs. 0.929, respectively), and both outperformed EAR (AUC = 0.890).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.